Antibe Therapeutics Inc. Announces Addition To Its Board Of Directors And Grant Of Options
5/12/2014 7:11:52 AM
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE) is pleased to announce the appointment of Samira Sakhia (B.Comm., MBA, CPA) to its Board of Directors. Ms. Sakhia has been the CFO of Paladin Labs Inc. since 2002, where she is responsible for leading the finance, operations, human resources, and investor relations teams. Ms. Sakhia has been a key member of the management team at Paladin and closely involved in the company’s strategy of in-licensing, acquiring products, and acquiring other specialty pharmaceutical companies in Canada and abroad.
Help employers find you! Check out all the jobs and post your resume.
comments powered by